Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief review.

J Clin Exp Hematop · 2021 · PMC8808108 · PMID 34511582

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

reported that 97% of 108 patients with newly diagnosed CHL had alterations in the PD-L1/PD-L2 loci, including copy gain (56%) and amplification (36%), revealing a highly significant association with the overexpression of both proteins.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.